drugset / Trial / NCT03148925
Safety and Pharmacodynamcis of SELA-070 Nicotine Vaccine in Smokers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and pharmacodynamics of SELA-070. Increasing subcutaneous doses of SELA-070 will be administered to healthy smoker volunteers. The resulting safety profile and anti-nicotine antibody levels will be evaluated.
Timeline
- Start
- 2017-05-11
- Primary completion
- 2018-10-18
- Completion
- 2018-10-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SELA-070 | Vaccine | — | Subcutaneous |
Indications
No indication recorded.